|
|
|
2008
| Date |
Publication |
| 07/30/08 |
Molecular Insight Pharmaceuticals, Inc. To Announce Second Quarter Financial Results on August 13, 2008 |
| 06/19/08 |
Molecular Insight Pharmaceuticals, Inc. To Present At Jefferies Healthcare Conference |
| 06/18/08 |
Molecular Insight Pharmaceuticals, Inc. Presents Three Studies on Trofex™ Program for Prostate Cancer Diagnosis and Staging |
| 06/18/08 |
Molecular Insight Pharmaceuticals, Inc. Reports Onalta™ Tissue Distribution Data Support Clinical Development Program |
| 06/16/08 |
Molecular Insight Pharmaceuticals, Inc. Announces Additional Panel Participation at the BIO 2008 International Convention |
| 06/16/08 |
Molecular Insight Pharmaceuticals, Inc. Reports Preclinical Data on Solazed™ for Treatment of Metastatic Melanoma at Society of Nuclear Medicine (SNM) Meeting |
| 06/12/08 |
Molecular Insight Pharmaceuticals, Inc. Initiates Trofex™ Phase 1 Trial for the Detection and Staging of Metastatic Prostate Cancer |
| 06/11/08 |
Molecular Insight Pharmaceuticals, Inc. Announces Panel Participation at the BIO 2008 International Convention |
| 06/02/08 |
Molecular Insight Pharmaceuticals, Inc. Reports Preliminary Results of Azedra™ Phase I Trial in Neuroendocrine Cancer Patients at ASCO |
| 05/20/08 |
Molecular Insight Pharmaceuticals, Inc. to Present Data on Four Oncology Candidates at Society of Nuclear Medicine 2008 Annual Meeting |
| 05/16/08 |
Molecular Insight Pharmaceuticals, Inc. To Present Interim Phase 1 Data at ASCO on Azedra™ in Malignant Pheochromocytoma/Paraganglioma Patients |
| 05/14/08 |
Molecular Insight Pharmaceuticals, Inc. Announces First Quarter 2008 Financial Results |
| 05/05/08 |
Molecular Insight Pharmaceuticals, Inc. To Announce First Quarter Financial Results on May 14, 2008 |
| 05/01/08 |
Molecular Insight Pharmaceuticals, Inc. Initiates Phase 2a Azedra™ Clinical Trial in Neuroblastoma Patients |
| 03/31/08 |
Molecular Insight Pharmaceuticals, Inc. Announces Fourth Quarter and Year-End 2007 Financial and Operational Results |
| 03/12/08 |
Molecular Insight Pharmaceuticals, Inc. to Announce Fourth Quarter and Year-End Financial Results on March 31, 2008 |
| 02/06/08 |
Molecular Insight Pharmaceuticals, Inc. To Present at BIO CEO & Investor Conference |
| 01/23/08 |
Molecular Insight Pharmaceuticals, Inc. To Present at Wachovia 2008 Healthcare Conference |
| 01/22/08 |
Molecular Insight Pharmaceuticals, Inc. to Host Analyst Day Event and Webcast February 5, 2008 |
2007
| Date |
Publication |
| 11/12/07 |
Molecular Insight Pharmaceuticals, Inc. Announces Third Quarter 2007 Financial Results |
| 11/09/07 |
Molecular Insight Pharmaceuticals, Inc. Prices $150 Million Bond Financing |
| 11/05/07 |
Molecular Insight Pharmaceuticals, Inc. To Announce Third Quarter Financial Results On November 12, 2007 |
| 10/25/07 |
Molecular Insight Pharmaceuticals, Inc. Presents Preclinical TrofexTM Prostate Cancer Data at AACR |
| 10/18/07 |
Molecular Insight Pharmaceuticals, Inc. Announces Positive Results of AzedraTM Phase 1 Dosimetry Trial for Neuroendocrine Tumors |
| 10/03/07 |
Molecular Insight Pharmaceuticals, Inc. Completes Strategic Purchase of Radiopharmaceutical Manufacturing Facility |
| 09/19/07 |
Molecular Insight Pharmaceuticals, Inc. To Present at 2007 UBS Global Life Sciences Conference |
| 09/11/07 |
Molecular Insight Pharmaceuticals, Inc. to Host Conference Call to Review Positive ZemivaTM Phase 2b Data Presented at ASNC |
| 09/10/07 |
Molecular Insight Pharmaceuticals, Inc. Announces Positive Results of Pilot Investigation of ZemivaTM in Emergency Department Setting |
| 09/07/07 |
ZemivaTM Normals Database From Molecular Insight Pharmaceuticals, Inc. Enables Accurate Determination of Abnormal Heart Activity |
| 08/29/07 |
Molecular Insight Pharmaceuticals, Inc. To Present At NewsMakers In The Biotech Industry Conference |
| 08/21/07 |
Former FDA Deputy Commissioner Scott Gottlieb, M.D. joins Molecular Insight Pharmaceuticals, Inc. Board of Directors |
| 08/16/07 |
Molecular Insight Pharmaceuticals, Inc. Announces Appointment of Donald E. Wallroth as Chief Financial Officer |
| 08/13/07 |
Molecular Insight Pharmaceuticals, Inc. Announces Second Quarter 2007 Financial Results |
| 08/06/07 |
Molecular Insight Pharmaceuticals, Inc. Selected to Present Zemiva™ Phase 2b Clinical Trial Data in Late Breaking Clinical Forum at American Society of Nuclear Cardiology Annual Meeting |
| 08/06/07 |
Molecular Insight Pharmaceuticals, Inc. To Announce Second Quarter Financial Results On August 13, 2007 |
| 06/25/07 |
Molecular Insight Pharmaceuticals, Inc. Initiates First of Two Planned Pivotal Registration Trials for Zemiva™ in Detection of Cardiac Ischemia |
| 06/20/07 |
Molecular Insight Pharmaceuticals, Inc. To Present At Jefferies Healthcare Conference |
| 06/04/07 |
Molecular Insight Pharmaceuticals, Inc. Presents Preclinical Data at Society Of Nuclear Medicine 2007 Annual Meeting |
| 06/04/07 |
Molecular Insight Pharmaceuticals, Inc. Presents Preclinical Data on Molecular Imaging Pharmaceutical for Prostate Cancer |
| 05/17/07 |
Molecular Insight Pharmaceuticals, Inc. Enters into Agreement to Purchase Radiopharmaceutical Manufacturing Facility |
| 05/15/07 |
Molecular Insight Pharmaceuticals, Inc. Announces First Quarter 2007 Financial Results |
| 05/10/07 |
Molecular Insight Pharmaceuticals, Inc. Initiates Azedra™ Therapeutic Trial in Neuroendocrine Cancer Patients |
| 05/09/07 |
Molecular Insight Pharmaceuticals, Inc. to Host Conference Call on May 15 |
| 05/01/07 |
Molecular Insight Pharmaceuticals, Inc. Announces Participation in Sessions at BIO 2007 International Convention |
| 04/23/07 |
Molecular Insight Pharmaceuticals, Inc. Announces Appointment of Norman LaFrance, M.D., as Senior Vice President, Clinical Development and Chief Medical Officer |
| 04/18/07 |
Molecular Insight Pharmaceuticals, Inc. Announces Appointment of Brian Abeysekera, Ph.D., as Vice President, Manufacturing |
| 04/13/07 |
Molecular Insight Pharmaceuticals, Inc. Announces Resignation of Chief Financial Officer |
| 02/02/07 |
Molecular Insight Pharmaceuticals, Inc. Announces Initial Public Offering |
| 01/24/07 |
Molecular Insight Pharmaceuticals, Inc. Acquires Clinical Stage, Targeted Radiotherapeutic Candidate Onalta™ (Formerly OctreoTher™) |
| 01/17/07 |
Molecular Insight Pharmaceuticals, Inc. Acquires Malignant Melanoma Radiotherapeutic Drug Candidate from Bayer Schering Pharma |
2006
Archive:
2005
2004
2003
Contact:
Priscilla Harlan
Vice President, Corporate Communications
Molecular Insight Pharmaceuticals, Inc.
(617) 492-5554
|
|